Literature DB >> 22345482

Latency type-dependent modulation of Epstein-Barr virus-encoded latent membrane protein 1 expression by type I interferons in B cells.

Daniel Salamon1, Monika Adori, Dorina Ujvari, Liang Wu, Lorand L Kis, Harsha S Madapura, Noemi Nagy, George Klein, Eva Klein.   

Abstract

We report that type I interferons (IFNs) upregulate latent membrane protein 1 (LMP-1) expression by direct activation of the ED-L1 promoter in several Epstein-Barr virus (EBV)-carrying Burkitt's lymphoma lines. In EBV-infected primary B cells, IFN-α transiently upregulates LMP-1 mRNA, but not protein levels, followed by downregulation of both, suggesting a novel antiproliferative mechanism of type I IFNs. Furthermore, our results may explain the expression of LMP-1 in memory B cells of systemic lupus erythematosus patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22345482      PMCID: PMC3318621          DOI: 10.1128/JVI.06829-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Host-cell-phenotype-dependent control of the BCR2/BWR1 promoter complex regulates the expression of Epstein-Barr virus nuclear antigens 2-6.

Authors:  E Altiok; J Minarovits; L F Hu; B Contreras-Brodin; G Klein; I Ernberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

2.  An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA.

Authors:  K Takada; K Horinouchi; Y Ono; T Aya; T Osato; M Takahashi; S Hayasaka
Journal:  Virus Genes       Date:  1991-04       Impact factor: 2.332

3.  Anti-proliferative effects of interferons on Daudi Burkitt lymphoma cells: induction of cell differentiation and loss of response to autocrine growth factors.

Authors:  R Exley; J Gordon; P Nathan; L Walker; M J Clemens
Journal:  Int J Cancer       Date:  1987-07-15       Impact factor: 7.396

4.  The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.

Authors:  I Ernberg; K Falk; J Minarovits; P Busson; T Tursz; M G Masucci; G Klein
Journal:  J Gen Virol       Date:  1989-11       Impact factor: 3.891

5.  The Epstein-Barr virus 3.5-kilobase latent membrane protein 1 mRNA initiates from a TATA-Less promoter within the first terminal repeat.

Authors:  R H Sadler; N Raab-Traub
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

6.  Sequence-specific methylation inhibits the activity of the Epstein-Barr virus LMP 1 and BCR2 enhancer-promoter regions.

Authors:  J Minarovits; L F Hu; S Minarovits-Kormuta; G Klein; I Ernberg
Journal:  Virology       Date:  1994-05-01       Impact factor: 3.616

7.  Inhibition of Epstein-Barr virus-mediated capping of CD21/CR2 by alpha interferon (IFN-alpha): immediate antiviral activity of IFN-alpha during the early phase of infection.

Authors:  A X Delcayre; M Lotz; W Lernhardt
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

8.  5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael.

Authors:  M G Masucci; B Contreras-Salazar; E Ragnar; K Falk; J Minarovits; I Ernberg; G Klein
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

9.  Effects of pure interferons on Epstein-Barr virus infection in vitro.

Authors:  J P Andersson; U G Andersson; I T Ernberg; S F Britton; M DeLey
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

10.  Transmembrane signaling by interferon alpha involves diacylglycerol production and activation of the epsilon isoform of protein kinase C in Daudi cells.

Authors:  L M Pfeffer; B L Eisenkraft; N C Reich; T Improta; G Baxter; S Daniel-Issakani; B Strulovici
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

View more
  10 in total

Review 1.  EBV Persistence--Introducing the Virus.

Authors:  David A Thorley-Lawson
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

2.  Induction of Epstein-Barr Virus Oncoprotein LMP1 by Transcription Factors AP-2 and Early B Cell Factor.

Authors:  Takayuki Murata; Chieko Noda; Yohei Narita; Takahiro Watanabe; Masahiro Yoshida; Keiji Ashio; Yoshitaka Sato; Fumi Goshima; Teru Kanda; Hironori Yoshiyama; Tatsuya Tsurumi; Hiroshi Kimura
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

Review 3.  Type 1 Diabetes and Type 1 Interferonopathies: Localization of a Type 1 Common Thread of Virus Infection in the Pancreas.

Authors:  Virginie S E Jean-Baptiste; Chang-Qing Xia; Michael J Clare-Salzler; Marc S Horwitz
Journal:  EBioMedicine       Date:  2017-06-21       Impact factor: 8.143

4.  Multiple Sclerosis-Like Symptoms in Mice Are Driven by Latent γHerpesvirus-68 Infected B Cells.

Authors:  Ana Citlali Márquez; Iryna Shanina; Marc Steven Horwitz
Journal:  Front Immunol       Date:  2020-11-19       Impact factor: 7.561

Review 5.  Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation.

Authors:  Andreas Lossius; Jorunn N Johansen; Øivind Torkildsen; Frode Vartdal; Trygve Holmøy
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

6.  Characterization of human Fab antibody fragments specific to LMP1 (HLEAFab) in nasopharyngeal carcinoma for potential molecular diagnosis and therapeutic applications.

Authors:  Dawei Zhang; Yuan Mao; Lin Xiong; Qing Cao; Jin Zhu; Renjie Chen
Journal:  Oncol Lett       Date:  2013-02-28       Impact factor: 2.967

Review 7.  The Role of Latently Infected B Cells in CNS Autoimmunity.

Authors:  Ana Citlali Márquez; Marc Steven Horwitz
Journal:  Front Immunol       Date:  2015-10-28       Impact factor: 7.561

8.  EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis.

Authors:  J Ma; K Nie; D Redmond; Y Liu; O Elemento; D M Knowles; W Tam
Journal:  Leukemia       Date:  2015-11-04       Impact factor: 11.528

9.  Cigarette smoke-induced lung inflammation in COPD mediated via CCR1/JAK/STAT /NF-κB pathway.

Authors:  Kaishun Zhao; Ran Dong; Yanfang Yu; Chunlin Tu; Ying Li; YuJuan Cui; Lei Bao; Chunhua Ling
Journal:  Aging (Albany NY)       Date:  2020-05-28       Impact factor: 5.682

10.  Epstein-Barr Functional Mimicry: Pathogenicity of Oncogenic Latent Membrane Protein-1 in Systemic Lupus Erythematosus and Autoimmunity.

Authors:  Melissa E Munroe; Jourdan R Anderson; Timothy F Gross; Laura L Stunz; Gail A Bishop; Judith A James
Journal:  Front Immunol       Date:  2021-02-03       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.